Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: a case study (Q33444139)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: a case study
scientific article

    Statements

    Enhanced bioavailability of a poorly soluble VR1 antagonist using an amorphous solid dispersion approach: a case study (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit